Theratechnologies to Present at the H.C. Wainwright Global Life Sciences Conference

MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) TH THTX, a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held virtually March 9 – 10, 2021.

The presentation will be available on demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET on the ‘News' section of the Company's website or via the virtual conference link, and will be archived for 90 days.

About Theratechnologies

Theratechnologies TH THTX is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:

Denis Boucher

Vice-President, Communications and Corporate Affairs

514-336-7800

For investor inquiries:

Leah Gibson

Senior Director, Investor Relations

lgibson@theratech.com

617-356-1009